BeStock  
Stocks › TARS

Tarsus Pharmaceuticals TARS

US equityMarket cap rank #2378
$74.46 +$1.46 (+1.99%)
Market closed · Oct 5, 10:20 pm ET · Last extended-hours $74.46 0.00%
Open$73.22
Prev close$73.00
Day range$72.76 – $75.00
Volume939.6K
Market cap$3.48B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$173.91M+69.4% YoY
Operating profit-$19.91M+10.3% YoY
Net profit-$18.55M+8.8% YoY
Diluted EPS-$0.43+10.4% YoY

Revenue, last 8 quarters

$48.1MSep '24$66.4MDec '24$78.3MMar '25$102.7MJun '25$118.7MSep '25$151.7MDec '25$162.1MMar '26$173.9MJun '26

Net profit, last 8 quarters

$-23.4MSep '24$-23.1MDec '24$-25.1MMar '25$-20.3MJun '25$-12.6MSep '25$-8.4MDec '25$-7.0MMar '26$-18.6MJun '26

Diluted EPS by quarter

-0.61Sep '24-0.60Dec '24-0.64Mar '25-0.48Jun '25-0.30Sep '25-0.20Dec '25-0.16Mar '26-0.43Jun '26

Profitability & balance sheet

Gross margin93.0%
Operating margin-11.4%
Net margin-10.7%

Income statement

Line item 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2
Non-Operating Interest Income $3.70M $3.72M $3.95M $4.11M $4.23M
Diluted EPS -$0.43 -$0.16 -$0.20 -$0.30 -$0.48
Net Non-Operating Interest Income (Expense) $1.54M $1.59M $1.74M $1.85M $1.99M
Operating Profit -$19.91M -$6.12M -$7.98M -$14.53M -$22.18M
Research & Development $31.01M $22.35M $18.04M $16.28M $15.59M
Selling and Admin Expenses $150.70M $136.43M $130.68M $108.63M $103.01M
Operating Expense $181.71M $158.78M $148.72M $124.92M $118.61M
Gross Profit $161.80M $152.66M $140.74M $110.39M $96.42M
Cost of Revenue $12.11M $9.40M $10.93M $8.31M $6.24M
Total Operating Revenue $173.91M $162.05M $151.67M $118.70M $102.66M
Total Revenue as Reported $173.91M $162.05M $151.67M $118.70M $102.66M
Non-Operating Interest Expense $1.99M $1.97M $2.06M $2.12M $2.09M
Total Other Finance Costs $165,000.00 $159,000.00 $156,000.00 $152,000.00 $146,000.00
Basic EPS -$0.43 -$0.16 -$0.20 -$0.30 -$0.48
Net Income to Common Stockholders -$18.55M -$6.97M -$8.37M -$12.59M -$20.34M
Net Income to Parent Company -$18.55M -$6.97M -$8.37M -$12.59M -$20.34M
Profit from Continuing Operations -$18.55M -$6.97M -$8.37M -$12.59M -$20.34M
Net Profit -$18.55M -$6.97M -$8.37M -$12.59M -$20.34M
Tax $2.72M $2.35M – – $0.00
Pretax Profit -$15.84M -$4.62M -$6.31M -$12.59M -$20.34M
Other Non-Operating Income (Expenses) -$281,000.00 -$87,000.00 -$74,000.00 $98,000.00 -$145,000.00
Gain on Sale of Security $2.81M – – – –
Other Income (Expense) $2.53M -$87,000.00 -$74,000.00 $98,000.00 -$145,000.00
Special Income (Charges) – – $0.00 $0.00 –

Discussion

No comments yet — be the first to weigh in on TARS.

Leave a comment

Scroll to Top